InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Silo Pharma, Inc.

SILO Clue Score33
United States Fiscal year ends December CIK 0001514183
$1.47 +1.38% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.47 +580.56% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−0.5Net income0.4EPS, diluted0.01Fiscal year 2018Operating income−0.6Net income−1.0 −371.9%EPS, diluted−0.02Fiscal year 2019Revenue0.0Operating income−0.9Net income−1.0Fiscal year 2020Revenue0.0 +0.9%Operating income−2.2Net income−3.0EPS, diluted−0.05Fiscal year 2021Operating income−2.7Net income3.9EPS, diluted0.04Fiscal year 2022Revenue0.1Operating income−3.6Net income−3.9 −200.1%EPS, diluted−1.71Fiscal year 2023Revenue0.1 +0.0%Operating income−3.9Net income−3.7EPS, diluted−1.20Fiscal year 2024Revenue0.1 +0.0%Operating income−4.7Net income−4.4EPS, diluted−1.19Fiscal year 2025Revenue0.1 +0.0%Operating income−4.3Net income−4.2EPS, diluted−0.50
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 0.0 n/a 0.1 0.1 0.1 0.1
Growth +0.9% +0.0% +0.0% +0.0%
Operating income −0.5 −0.6 −0.9 −2.2 −2.7 −3.6 −3.9 −4.7 −4.3
Net income 0.4 −1.0 −1.0 −3.0 3.9 −3.9 −3.7 −4.4 −4.2
Growth −371.9% −200.1%
EPS, diluted 0.01 −0.02 n/a −0.05 0.04 −1.71 −1.20 −1.19 −0.50

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Fiscal year 2018Fiscal year 2019Gross margin32.5%Operating margin−2,293.4%Net margin−2,497.7%Fiscal year 2020Gross margin−330.4%Operating margin−5,380.2%Net margin−7,422.5%Fiscal year 2021Fiscal year 2022Gross margin91.9%Operating margin−5,031.3%Net margin−5,420.9%Fiscal year 2023Gross margin91.9%Operating margin−5,347.4%Net margin−5,132.6%Fiscal year 2024Gross margin91.9%Operating margin−6,526.4%Net margin−6,092.6%Fiscal year 2025Gross margin38.6%Operating margin−5,937.0%Net margin−5,863.5%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a 32.5% −330.4% n/a 91.9% 91.9% 91.9% 38.6%
Operating margin n/a n/a −2,293.4% −5,380.2% n/a −5,031.3% −5,347.4% −6,526.4% −5,937.0%
Net margin n/a n/a −2,497.7% −7,422.5% n/a −5,420.9% −5,132.6% −6,092.6% −5,863.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2017Operating cash flow−0.3Fiscal year 2018Operating cash flow0.3Fiscal year 2019Operating cash flow−0.8Fiscal year 2020Operating cash flow−1.2Fiscal year 2021Operating cash flow−2.3Fiscal year 2022Operating cash flow−3.5Fiscal year 2023Operating cash flow−3.2Fiscal year 2024Operating cash flow−3.8Fiscal year 2025Operating cash flow−4.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.3 0.3 −0.8 −1.2 −2.3 −3.5 −3.2 −3.8 −4.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash0.3Shareholders’ equity1.2Fiscal year 2018Cash0.3Shareholders’ equity0.4Fiscal year 2019Cash0.1Shareholders’ equity−0.0Fiscal year 2020Cash1.1Shareholders’ equity1.3Fiscal year 2021Cash9.8Shareholders’ equity9.1Fiscal year 2022Cash11.4Shareholders’ equity10.3Fiscal year 2023Cash3.5Shareholders’ equity6.2Fiscal year 2024Cash3.9Shareholders’ equity5.0Fiscal year 2025Cash4.7Shareholders’ equity6.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.3 0.3 0.1 1.1 9.8 11.4 3.5 3.9 4.7
Shareholders’ equity 1.2 0.4 −0.0 1.3 9.1 10.3 6.2 5.0 6.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
n/a n/a 0.0 0.0 n/a 0.1 0.1 0.1 0.1
Growth +0.9% +0.0% +0.0% +0.0%
n/a n/a 0.0 0.2 0.0 0.0 0.0 0.0 0.0
n/a n/a 0.0 −0.1 0.1 0.1 0.1 0.1 0.0
Growth −1,125.7% +0.0% +0.0% +0.0% −58.0%
n/a n/a n/a 0.0 0.7 1.3 0.8 2.4 2.2
0.0 0.1 0.1 0.1 0.2 0.2 0.4 n/a n/a
−0.5 −0.6 −0.9 −2.2 −2.7 −3.6 −3.9 −4.7 −4.3
Growth
n/a n/a n/a −2.7 4.2 −3.9 −3.6 −4.4 −4.2
n/a n/a n/a n/a 0.0 n/a n/a n/a n/a
0.4 −1.0 −1.0 −3.0 3.9 −3.9 −3.7 −4.4 −4.2
Growth −371.9% −200.1%
Per share
0.01 −0.02 n/a −0.05 0.04 −1.71 −1.20 −1.19 −0.50
0.01 −0.02 n/a −0.05 0.04 −1.71 −1.20 −1.19 −0.50
Growth −300.0% −4,375.0%
n/a n/a n/a 66.0 1.9 2.3 3.1 3.7 8.4
52.1 49.1 n/a 66.0 1.9 2.3 3.1 3.7 8.4
Growth −5.7% −97.1% +19.1% +34.8% +19.5% +127.8%

† The diluted share count jumps at 2021 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 12.2% a year over five years.
  • Operating margin is down 3,643.6 points on five years ago, at -5,937.0%.
  • A net loss in 7 of 9 years on file.